Pembrolizumab in Non-Small-Cell Lung Cancer REPLY

被引：0
|
作者：
Reck, Martin [1 ]
Brahmer, Julie R. [2 ]
机构：
[1] German Ctr Lung Res, Grosshansdorf, Germany
[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：997 / 997
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10) : 996 - 997
  • [2] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
    Garon, Edward B.
    Rizvi, Naiyer A.
    Hui, Rina
    Leighl, Natasha
    Balmanoukian, Ani S.
    Eder, Joseph Paul
    Patnaik, Amita
    Aggarwal, Charu
    Gubens, Matthew
    Horn, Leora
    Carcereny, Enric
    Ahn, Myung-Ju
    Felip, Enriqueta
    Lee, Jong-Seok
    Hellmann, Matthew D.
    Hamid, Omid
    Goldman, Jonathan W.
    Soria, Jean-Charles
    Dolled-Filhart, Marisa
    Rutledge, Ruth Z.
    Zhang, Jin
    Lunceford, Jared K.
    Rangwala, Reshma
    Lubiniecki, Gregory M.
    Roach, Charlotte
    Emancipator, Kenneth
    Gandhi, Leena
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) : 2018 - 2028
  • [3] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
    Vozy, A.
    Zalcman, G.
    ONCOLOGIE, 2015, 17 (09) : 407 - 408
  • [4] Pembrolizumab as adjuvant therapy in non-small-cell lung cancer
    Ganguly, Shuvadeep
    Gogia, Ajay
    LANCET ONCOLOGY, 2022, 23 (12) : E528 - E528
  • [5] Adagrasib in Non-Small-Cell Lung Cancer REPLY
    Janne, Pasi A.
    Sabari, Joshua K.
    Spira, Alexander I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13) : 1239 - 1239
  • [6] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
    Gandhi, L.
    Rodriguez-Abreu, D.
    Gadgeel, S.
    Esteban, E.
    Felip, E.
    De Angelis, F.
    Domine, M.
    Clingan, P.
    Hochmair, M. J.
    Powell, S. F.
    Cheng, S. Y. -S.
    Bischoff, H. G.
    Peled, N.
    Grossi, F.
    Jennens, R. R.
    Reck, M.
    Hui, R.
    Garon, E. B.
    Boyer, M.
    Rubio-Viqueira, B.
    Novello, S.
    Kurata, T.
    Gray, J. E.
    Vida, J.
    Wei, Z.
    Yang, J.
    Raftopoulos, H.
    Pietanza, M. C.
    Garassino, M. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) : 2078 - 2092
  • [7] Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
    Paz-Ares, L.
    Luft, A.
    Vicente, D.
    Tafreshi, A.
    Gumus, M.
    Mazieres, J.
    Hermes, B.
    Senler, F. Cay
    Csoszi, T.
    Fulop, A.
    Rodriguez-Cid, J.
    Wilson, J.
    Sugawara, S.
    Kato, T.
    Lee, K. H.
    Cheng, Y.
    Novello, S.
    Halmos, B.
    Li, X.
    Lubiniecki, G. M.
    Piperdi, B.
    Kowalski, D. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21) : 2040 - 2051
  • [8] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY
    Cataldo, Vince D.
    Gibbons, Don L.
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24) : 2368 - 2368
  • [9] Anthropometric measurements in non-small-cell lung cancer - Reply
    Ferrigno, D
    SUPPORTIVE CARE IN CANCER, 2002, 10 (05) : 440 - 440
  • [10] Postoperative radiotherapy in non-small-cell lung cancer - Reply
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (03) : 136 - 137
12345